X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24112) 24112
Magazine Article (91) 91
Newsletter (28) 28
Book Chapter (13) 13
Transcript (8) 8
Dissertation (5) 5
Publication (5) 5
Newspaper Article (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21635) 21635
prednisolone - therapeutic use (17755) 17755
female (13187) 13187
male (12875) 12875
adult (8760) 8760
middle aged (8321) 8321
aged (5066) 5066
prednisolone - administration & dosage (4409) 4409
prednisolone (4115) 4115
adolescent (3719) 3719
treatment outcome (3667) 3667
glucocorticoids - therapeutic use (3627) 3627
anti-inflammatory agents - therapeutic use (3367) 3367
drug therapy, combination (3180) 3180
child (3029) 3029
immunosuppressive agents - therapeutic use (2391) 2391
animals (2113) 2113
corticosteroids (2111) 2111
antineoplastic combined chemotherapy protocols - therapeutic use (2035) 2035
child, preschool (1810) 1810
follow-up studies (1711) 1711
medicine, general & internal (1595) 1595
time factors (1580) 1580
azathioprine - therapeutic use (1555) 1555
prednisolone - adverse effects (1508) 1508
therapy (1440) 1440
retrospective studies (1429) 1429
cyclophosphamide - therapeutic use (1419) 1419
rheumatology (1399) 1399
prognosis (1394) 1394
diagnosis, differential (1376) 1376
infant (1197) 1197
vincristine - administration & dosage (1196) 1196
cyclophosphamide - administration & dosage (1168) 1168
biopsy (1150) 1150
surgery (1128) 1128
recurrence (1124) 1124
immunology (1054) 1054
oncology (1042) 1042
medicine & public health (1037) 1037
administration, oral (1035) 1035
remission induction (1019) 1019
pediatrics (1017) 1017
steroids (1011) 1011
aged, 80 and over (999) 999
transplantation (995) 995
ophthalmology (990) 990
hematology (975) 975
care and treatment (927) 927
disease (924) 924
cyclosporine - therapeutic use (901) 901
children (900) 900
doxorubicin - administration & dosage (886) 886
glucocorticoids - administration & dosage (862) 862
prospective studies (861) 861
dermatology (845) 845
acute disease (840) 840
gastroenterology & hepatology (826) 826
adrenal cortex hormones - therapeutic use (816) 816
drug therapy (814) 814
arthritis, rheumatoid - drug therapy (798) 798
chronic disease (796) 796
pharmacology & pharmacy (778) 778
drug administration schedule (773) 773
combined modality therapy (771) 771
diagnosis (753) 753
tomography, x-ray computed (748) 748
magnetic resonance imaging (741) 741
prednisone - therapeutic use (740) 740
dose-response relationship, drug (733) 733
methylprednisolone - therapeutic use (731) 731
young adult (722) 722
glucocorticoids (711) 711
anti-inflammatory agents - administration & dosage (707) 707
asthma - drug therapy (697) 697
prednisolone - pharmacology (694) 694
methotrexate - therapeutic use (676) 676
risk factors (675) 675
urology & nephrology (671) 671
vincristine - therapeutic use (655) 655
chemotherapy (646) 646
severity of illness index (632) 632
prednisolone - analogs & derivatives (630) 630
double-blind method (627) 627
analysis (617) 617
patients (611) 611
health aspects (605) 605
inflammation (599) 599
lupus erythematosus, systemic - drug therapy (592) 592
research article (581) 581
rats (575) 575
clinical trials as topic (554) 554
management (540) 540
anti-bacterial agents - therapeutic use (534) 534
pregnancy (532) 532
nephrotic syndrome - drug therapy (515) 515
kidney transplantation (514) 514
rituximab (514) 514
administration, topical (513) 513
clinical neurology (512) 512
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19706) 19706
Japanese (1512) 1512
German (1400) 1400
Russian (1023) 1023
French (392) 392
Italian (190) 190
Spanish (152) 152
Hungarian (82) 82
Polish (69) 69
Danish (50) 50
Dutch (48) 48
Chinese (46) 46
Ukrainian (42) 42
Swedish (39) 39
Portuguese (36) 36
Korean (28) 28
Norwegian (23) 23
Bulgarian (13) 13
Finnish (13) 13
Lithuanian (10) 10
Serbian (8) 8
Hebrew (7) 7
Romanian (7) 7
Turkish (7) 7
Croatian (4) 4
Czech (2) 2
Greek (2) 2
Bosnian (1) 1
Icelandic (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | DENILEUKIN DIFTITOX | NON-HODGKINS-LYMPHOMAS | FOLLOW-UP | BRENTUXIMAB VEDOTIN SGN-35 | OPEN-LABEL | ALLOGENEIC TRANSPLANTATION | SINGLE-AGENT | PHASE-II TRIAL | ONCOLOGY | SALVAGE THERAPY | HIGH-DOSE CHEMOTHERAPY | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD003594
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 8, p. CD001955
Background Glucocorticoids are commonly used for croup in children. This is an update of a Cochrane Review published in 1999 and previously updated in 2004 and... 
Epinephrine | Croup/epiglottitis | Budesonide | Dexamethasone | Lungs & airways | Glucocorticoids | Respiratory infections: croup/epiglottitis | Fluticasone | Randomized Controlled Trials as Topic | Ear, nose, & throat | Infectious disease | Beclomethasone | Treatment | Child health | Respiratory infections | Larynx | Betamethasone | Medicine General & Introductory Medical Sciences | Croup | Prednisolone | Ear, nose & throat | Steroids | Epinephrine [therapeutic use] | Severity of Illness Index | NEBULIZED RACEMIC EPINEPHRINE | STEROID TREATMENT | INTRAMUSCULAR DEXAMETHASONE | Budesonide [therapeutic use] | Croup [drug therapy] | Dexamethasone [therapeutic use] | Humans | RANDOMIZED DOUBLE-BLIND | VIRAL CROUP | Androstadienes [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [therapeutic use] | EMERGENCY-DEPARTMENTS | Time Factors | Prednisolone [therapeutic use] | OUTPATIENT TREATMENT | TREATING CROUP | PLACEBO-CONTROLLED TRIAL | ORAL DEXAMETHASONE | Child | Glucocorticoids - therapeutic use | Croup - drug therapy | Child, Preschool | Infant | Fluticasone - therapeutic use | Dexamethasone - therapeutic use | Epinephrine - therapeutic use | Budesonide - therapeutic use | Adolescent | Prednisolone - therapeutic use | Betamethasone - therapeutic use | Beclomethasone - therapeutic use | Infant, Newborn
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
... of splenectomy (Splx) as the first and still successfully used therapeutic measure in management of immune thrombocytopenia (ITP) [1]. The second therapeutic measure... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Pediatric Drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 4, p. CD006545
Background Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 10, p. CD001446
Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be... 
Guillain‐Barre Syndrome | Glucocorticoids | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Child health | Guillain‐Barré syndrome | Anti‐Inflammatory Agents | Adrenocorticotropic Hormone | Medicine General & Introductory Medical Sciences | Prednisolone | Corticosteroid treatment | GLOMERULONEPHRITIS | Methylprednisolone [administration & dosage; therapeutic use] | STEROIDS | Humans | Prednisolone [administration & dosage; therapeutic use] | Adrenocorticotropic Hormone [administration & dosage;therapeutic use] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | METHYLPREDNISOLONE | Guillain-Barre Syndrome [drug therapy] | TRIAL | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | PREDNISONE | THERAPY | STANDARD TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | Anti-Inflammatory Agents [administration & dosage;therapeutic use] | Adult | Glucocorticoids [administration & dosage; therapeutic use] | Child | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisolone - administration & dosage | Methylprednisolone - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Guillain-Barre Syndrome - drug therapy | Adrenocorticotropic Hormone - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisolone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 6, p. CD003725
...), and strength at two years (two‐year data on function are very limited). Corticosteroids, now part of care recommendations for DMD, are largely in routine use, although... 
Muscle Diseases | Pregnenediones | Glucocorticoids | Adrenal Cortex Hormones | Prednisone | Randomized Controlled Trials as Topic | Walking | Neurology | Duchenne muscular dystrophy | Child health | Quality of Life | Muscular dystrophies | Muscle disease | Muscular Dystrophy, Duchenne | Medicine General & Introductory Medical Sciences | Muscle Strength | Prednisolone | Corticosteroid treatment | AMERICAN ACADEMY | CONTROLLED-TRIAL | LOW-DOSAGE | Humans | Male | Adrenal Cortex Hormones [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [adverse effects; therapeutic use] | PREDNISONE TREATMENT | Prednisolone [therapeutic use] | Prednisone [therapeutic use] | DEFLAZACORT TREATMENT | GLYCOPROTEIN COMPLEX | DOUBLE-BLIND | Muscular Dystrophy, Duchenne [drug therapy] | MOLECULAR PATHOGENESIS | Pregnenediones [therapeutic use] | STEROID-THERAPY | LONG-TERM TREATMENT | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Muscular Dystrophy, Duchenne - drug therapy | Pregnenediones - administration & dosage | Adrenal Cortex Hormones - therapeutic use | Pregnenediones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Muscle Strength - drug effects | Prednisolone - therapeutic use | Glucocorticoids - adverse effects | Prednisone - therapeutic use | Adrenal Cortex Hormones - administration & dosage
Journal Article